Blue Ridge Bankshares, Inc. Releases 2013 Earnings LURAY,

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
Blue Ridge Bankshares, Inc. Releases 2013 Earnings

LURAY, Va., Jan. 28, 2013 /PRNewswire/ -- Blue Ridge Bankshares, Inc. (OTCQB: BRBS), parent company of Blue Ridge Bank, announced today its financial results for the year ended Dec. 31, 2013—reporting the highest net income in the company's history and marking its fifth consecutive year of record earnings.

(Logo: http://photos.prnewswire.com/prnh/20130813/NE63024LOGO)

Blue Ridge Bankshares reported net income of $1,845,000 for the year, or $1.75 per common share, compared to $1,516,000 of net income for 2012, or $1.40 per common share.  The increase in earnings per common share represents growth of 25 percent from year-to-year.

The company experienced asset growth of $6,500,000, or 3.1 percent, for the year. Its held-for-investment loan portfolio grew $28,731,000, or 22.6 percent, during the year, while experiencing a decline of $10,793,000 in loans held-for-sale.

"I am very proud of our performance in recent years," said President and Chief Executive Officer Monte L. Layman. "While many of our peers have suffered through the past several years, Blue Ridge Bankshares has continued to improve profitability and increase its common stock dividends."

"While we have grown the balance sheet significantly, we have remained cautious and conservative in our lending approach—we feel that we have built a loan portfolio that will perform well in the future," said Layman.

Layman said the company remains committed to growing in a prudent and reasonable fashion.

"We plan to make an entry into a new market in the first half of 2014 that we believe will help further improve the bank's long-term growth prospects," he said.

About Blue Ridge Bankshares, Inc.
Blue Ridge Bankshares, Inc. is single-bank holding company headquartered in Luray, Va. Chartered in 1893, Blue Ridge Bank is a locally owned, independent community bank with four branches in the Shenandoah Valley and central Virginia. Visit www.mybrb.com for more information on the bank's wide range of financial services.

Forward-Looking Statements
This press release may contain "forward-looking statements" as defined by federal securities laws, which may involve significant risks and uncertainties. These statements address issues that involve risks, uncertainties, estimates and assumptions made by management, and actual results could differ materially from the results contemplated by these forward-looking statements. Factors that could have a material adverse effect on our operations and future prospects include, but are not limited to, changes in interest rates, general economic conditions and legislative and regulatory policies. Readers should consider these risks and uncertainties in evaluating forward-looking statements and should not place undue reliance on such statements. We undertake no obligation to update these statements following the date of this news release.

Contact
Brian K. Plum, Executive Vice President and Chief Financial Officer
Blue Ridge Bank
540-843-5207
bplum@mybrb.com

SOURCE Blue Ridge Bankshares, Inc.


Copyright 2013 PR Newswire
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 2

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 1

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 4

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 3

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 0

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 11

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 0

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 2

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading

Top 5 Most Recently Viewed Articles

Blackline Safety Posts 27% Revenue Surge in Fiscal Year 2024

Updated Category News Views 434

Blackline Safety's Fiscal Year 2024 Financial Performance Blackline Safety Corp. (TSX: BLN) has made impressive strides in its financial outcomes for the recent fiscal year. The company reports a remarkable total revenue of $127.3 million for 2024, marking a significant 27% increase year-over-year. These results demonstrate the effectiveness of the company's strategic...

Continue Reading
Government Projects India's Economic Growth at 6.5% for FY25

Updated Category News Views 237

Economic Growth Projections for India in FY25 The Indian economy is set to grow at an estimated rate of 6.5% during the fiscal year 2024/25. This projection, provided by government officials, aligns closely with the lower end of a broader range set between 6.5% and 7%. This outlook is framed against a backdrop of global uncertainties that could impact domestic growth...

Continue Reading
Investors Urged to Act on NANO Nuclear Energy Fraud Claims

Updated Category News Views 75

Overview of NANO Nuclear Energy NANO Nuclear Energy Inc. has recently found itself in the news due to a securities fraud lawsuit filed against the company. This situation serves as a crucial reminder for investors to actively seek information about their rights and options for potential recovery. Lawsuit Details The case, referred to as Yang v. Nano Nuclear Energy, Inc.,...

Continue Reading
Westinghouse Air Brake Technologies: A Potential Rebound Ahead

Updated Category News Views 127

Understanding Westinghouse's Current Position Shares of Westinghouse Air Brake Technologies Corporation (WAB) recently faced significant declines following disappointing earnings reports. However, the stock now appears to be positioned for a possible rally. Oversold Conditions and Key Support Levels The latest performance indicates that shares have become oversold,...

Continue Reading
BrainStorm Announces New Date for First Quarter Financial Call

Updated Category News Views 261

BrainStorm Reschedules Q1 2025 Financial Results Release BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a pioneer in adult stem cell therapeutics for neurodegenerative diseases, recently announced an important update regarding its financial results. The company has moved the release date for its financial performance for the first quarter, which ended on March 31,...

Continue Reading